NDC 49281-589

Menactra

Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen

Menactra is a Intramuscular Injection, Solution in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen; Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen; Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen; Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen.

• Product ID: 49281-589_82c32ea8-43a9-453a-86a2-32aaac828f53
• NDC: 49281-589
• Product Type: Vaccine
• Proprietary Name: Menactra
• Generic Name: Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2005-01-14
• Marketing Category: BLA / BLA
• Application Number: BLA125089
• Labeler Name: Sanofi Pasteur Inc.
• Substance Name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN
• Active Ingredient Strength: 4 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
• Pharm Classes: Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [CS],Vaccines, Inactivated [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 49281-589-05

5 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-589-05) > .5 mL in 1 VIAL, SINGLE-DOSE (49281-589-58)

• Marketing Start Date: 2005-01-14
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49281-589-05 [49281058905]

Menactra INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125089
• Product Type: VACCINE
• Billing Unit: ML
• Marketing Start Date: 2005-01-14

NDC 49281-589-58 [49281058958]

Menactra INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125089
• Product Type: VACCINE
• Billing Unit: ML
• Marketing Start Date: 2014-12-12

Drug Details

Active Ingredients

Ingredient	Strength
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN	4 ug/.5mL

Pharmacological Class

• Inactivated Meningococcal Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Meningococcal Vaccines [CS]
• Vaccines
• Inactivated [CS]
• Inactivated Meningococcal Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Meningococcal Vaccines [CS]
• Vaccines
• Inactivated [CS]
• Inactivated Meningococcal Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Meningococcal Vaccines [CS]
• Vaccines
• Inactivated [CS]
• Inactivated Meningococcal Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Meningococcal Vaccines [CS]
• Vaccines
• Inactivated [CS]